BioSpace News Archive

We are in the middle of winter, making extreme weather conditions and power outages more common.

Applied BioMath (www.appliedbiomath.com), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), today announced their participation at the Next-Generation Conjugates Summit occurring February 21-23, 2023 in Boston, MA.

AstraZeneca and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the final analysis of the key secondary endpoint of overall survival (OS) from the Phase 3 PROpel trial evaluating LYNPARZA in combination with abiraterone and prednisone or prednisolone (abi/pred), compared to placebo plus abi/pred.

Cure Rare Disease has been awarded an advocacy collaboration grant from the Muscular Dystrophy Association to support research on novel reimbursement strategies for drugs developed for ultra-rare diseases, a key challenge for rare disease patients, including muscular dystrophy patients.

Pixium Vision SA, a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, informs its shareholders that its extraordinary shareholder meeting, convened a second call to vote on the same agenda as the extraordinary shareholder meeting of February 15, 2023.

Independent biopharmaceutical company Specialised Therapeutics is pleased to announce that its portfolio therapy to treat rare soft tissue sarcomas has now been approved in New Zealand.

Subgroup analyses from the pivotal Phase III ARASENS trial support overall survival (OS) benefits of NUBEQA® (darolutamide) plus androgen deprivation therapy (ADT) and docetaxel compared to ADT and docetaxel in patients with high-volume and high and low-risk metastatic hormone-sensitive prostate cancer (mHSPC).

Terumo Blood and Cell Technologies announces U.S. FDA clearance and official launch of its IMUGARD® WB Platelet Pooling Set, which supports extended shelf life of whole blood-derived platelets from five days to seven days..

STRATA Skin Sciences, Inc. announced that Joel L. Cohen, MD, Director of AboutSkin Dermatology in Greenwood Village, Colorado, will be speaking during the live patient demonstration of the TheraClear®X device, FDA-cleared for the treatment of mild-to-moderate acne, including comedonal, pustular, and inflammatory acne vulgaris, at the inaugural Winter Clinical Conference at the InterContinental in Miami, Florida from February 17-20, 2023.

Vaxcyte, Inc. announced that it will report financial results for the fourth quarter and full year 2022 after market close on February 27, 2023.